159 related articles for article (PubMed ID: 31288011)
1. Second Primary Cancers in Patients with Invasive and In Situ Squamous Cell Skin Carcinoma, Kaposi Sarcoma, and Merkel Cell Carcinoma: Role for Immune Mechanisms?
Chattopadhyay S; Hemminki A; Försti A; Sundquist K; Sundquist J; Hemminki K
J Invest Dermatol; 2020 Jan; 140(1):48-55.e1. PubMed ID: 31288011
[TBL] [Abstract][Full Text] [Related]
2. Second primary cancers in patients with acute lymphoblastic, chronic lymphocytic and hairy cell leukaemia.
Zheng G; Chattopadhyay S; Sud A; Sundquist K; Sundquist J; Försti A; Houlston R; Hemminki A; Hemminki K
Br J Haematol; 2019 Apr; 185(2):232-239. PubMed ID: 30706458
[TBL] [Abstract][Full Text] [Related]
3. Second primary cancers in non-Hodgkin lymphoma: Bidirectional analyses suggesting role for immune dysfunction.
Chattopadhyay S; Sud A; Zheng G; Yu H; Sundquist K; Sundquist J; Försti A; Houlston R; Hemminki A; Hemminki K
Int J Cancer; 2018 Nov; 143(10):2449-2457. PubMed ID: 30238973
[TBL] [Abstract][Full Text] [Related]
4. Influence of family history on risk of second primary cancers and survival in patients with squamous cell skin cancer.
Chattopadhyay S; Zheng G; Hemminki A; Försti A; Sundquist K; Sundquist J; Hemminki K
Br J Dermatol; 2020 Sep; 183(3):488-494. PubMed ID: 31853941
[TBL] [Abstract][Full Text] [Related]
5. Impact of family history of cancer on risk and mortality of second cancers in patients with prostate cancer.
Chattopadhyay S; Hemminki O; Försti A; Sundquist K; Sundquist J; Hemminki K
Prostate Cancer Prostatic Dis; 2019 Mar; 22(1):143-149. PubMed ID: 30185889
[TBL] [Abstract][Full Text] [Related]
6. Subsequent cancers after in situ and invasive squamous cell carcinoma of the skin.
Hemminki K; Dong C
Arch Dermatol; 2000 May; 136(5):647-51. PubMed ID: 10815858
[TBL] [Abstract][Full Text] [Related]
7. Spectrum of Nonkeratinocyte Skin Cancer Risk Among Solid Organ Transplant Recipients in the US.
Sargen MR; Cahoon EK; Yu KJ; Madeleine MM; Zeng Y; Rees JR; Lynch CF; Engels EA
JAMA Dermatol; 2022 Apr; 158(4):414-425. PubMed ID: 35262623
[TBL] [Abstract][Full Text] [Related]
8. Merkel cell carcinoma: incidence, mortality, and risk of other cancers.
Kaae J; Hansen AV; Biggar RJ; Boyd HA; Moore PS; Wohlfahrt J; Melbye M
J Natl Cancer Inst; 2010 Jun; 102(11):793-801. PubMed ID: 20424236
[TBL] [Abstract][Full Text] [Related]
9. Second cancers following the diagnosis of Merkel cell carcinoma: a nationwide cohort study.
Koljonen V; Kukko H; Tukiainen E; Böhling T; Sankila R; Joensuu H; Pukkala E
Cancer Epidemiol; 2010 Feb; 34(1):62-5. PubMed ID: 20061203
[TBL] [Abstract][Full Text] [Related]
10. Rate differences between first and second primary cancers may outline immune dysfunction as a key risk factor.
Zheng G; Sundquist K; Sundquist J; Försti A; Hemminki A; Hemminki K
Cancer Med; 2020 Nov; 9(21):8258-8265. PubMed ID: 32960498
[TBL] [Abstract][Full Text] [Related]
11. Incidence Differences Between First Primary Cancers and Second Primary Cancers Following Skin Squamous Cell Carcinoma as Etiological Clues.
Zheng G; Sundquist K; Sundquist J; Försti A; Hemminki A; Hemminki K
Clin Epidemiol; 2020; 12():857-864. PubMed ID: 32821171
[TBL] [Abstract][Full Text] [Related]
12. Risk of Rare Cancers Among Solid Organ Transplant Recipients.
D'Arcy ME; Castenson D; Lynch CF; Kahn AR; Morton LM; Shiels MS; Pfeiffer RM; Engels EA
J Natl Cancer Inst; 2021 Feb; 113(2):199-207. PubMed ID: 32462187
[TBL] [Abstract][Full Text] [Related]
13. Second cancers and causes of death in patients with testicular cancer in Sweden.
Zhang L; Hemminki O; Chen T; Yu H; Zheng G; Chattopadhyay S; Försti A; Sundquist K; Sundquist J; Hemminki K
PLoS One; 2019; 14(3):e0214410. PubMed ID: 30921367
[TBL] [Abstract][Full Text] [Related]
14. Increased incidence of malignant melanoma and other rare cutaneous cancers in the setting of chronic lymphocytic leukemia.
Brewer JD; Shanafelt TD; Call TG; Cerhan JR; Roenigk RK; Weaver AL; Otley CC
Int J Dermatol; 2015 Aug; 54(8):e287-93. PubMed ID: 25772131
[TBL] [Abstract][Full Text] [Related]
15. Merkel cell carcinoma in Israel.
Brenner B; Katz A; Rakowski E; Feinmesser M; Bar Hanna M; Sulkes A; Fenig E
Isr J Med Sci; 1996 Dec; 32(12):1235-8. PubMed ID: 9007162
[TBL] [Abstract][Full Text] [Related]
16. Bladder and upper urinary tract cancers as first and second primary cancers.
Zheng G; Sundquist K; Sundquist J; Försti A; Hemminki O; Hemminki K
Cancer Rep (Hoboken); 2021 Dec; 4(6):e1406. PubMed ID: 34114732
[TBL] [Abstract][Full Text] [Related]
17. Incidence trends of squamous cell and rare skin cancers in the Swedish national cancer registry point to calendar year and age-dependent increases.
Hussain SK; Sundquist J; Hemminki K
J Invest Dermatol; 2010 May; 130(5):1323-8. PubMed ID: 20090766
[TBL] [Abstract][Full Text] [Related]
18. Risk of second primary cancers in women diagnosed with endometrial cancer in German and Swedish cancer registries.
Chen T; Brenner H; Fallah M; Jansen L; Castro FA; Geiss K; Holleczek B; Katalinic A; Luttmann S; Sundquist K; Ressing M; Xu L; Hemminki K;
Int J Cancer; 2017 Dec; 141(11):2270-2280. PubMed ID: 28815572
[TBL] [Abstract][Full Text] [Related]
19. Dermatopathology of skin cancer in solid organ transplant recipients.
Stoff B; Salisbury C; Parker D; O'Reilly Zwald F
Transplant Rev (Orlando); 2010 Oct; 24(4):172-89. PubMed ID: 20709518
[TBL] [Abstract][Full Text] [Related]
20. Cutaneous neoplasms in renal transplant recipients.
Rubel JR; Milford EL; Abdi R
Eur J Dermatol; 2002; 12(6):532-5. PubMed ID: 12459521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
